...
首页> 外文期刊>American Journal of Physiology >Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.
【24h】

Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.

机译:胃泌素释放肽通过局部黏着激酶上调细胞内黏附蛋白-1(ICAM-1)介导人结肠癌的形态发生特性。

获取原文
获取原文并翻译 | 示例

摘要

Gastrin-releasing peptide (GRP) and its receptor (GRPR) act as morphogens when expressed in colorectal cancer (CRC), promoting the assumption of a better differentiated phenotype by regulating cell motility in the context of remodeling and retarding tumor cell metastasis by enhancing cell-matrix attachment. Although we have shown that these processes are mediated by focal adhesion kinase (FAK), the downstream target(s) of GRP-induced FAK activation are not known. Since osteoblast differentiation is mediated by FAK-initiated upregulation of ICAM-1 (Nakayamada S, Okada Y, Saito K, Tamura M, Tanaka Y. J Biol Chem 278: 45368-45374, 2003), we determined whether GRP-induced activation of FAK alters ICAM-1 expression in CRC and, if so, determined the contribution of ICAM-1 to mediating GRP's morphogenic properties. Caco-2 and HT-29 cells variably express GRP/GRPR. These cells only express ICAM-1 when GRPR are present. In human CRC, GRPR and ICAM-1 are only expressed by better differentiated tumor cells, with ICAM-1 located at the basolateral membrane. ICAM-1 expression was only observed subsequent to GRPR signaling via FAK. To study the effect of ICAM-1 expression on tumor cell motility, CRC cells expressing GRP, GRPR, and ICAM-1 were cultured in the presence and absence of GRPR antagonist or monoclonal antibody to ICAM-1. CRC cells engaged in directed motility in the context of remodeling and were highly adherent to the extracellular matrix, only in the absence of antagonist or ICAM-1 antibody. These data indicate that GRP upregulation of ICAM-1 via FAK promotes tumor cell motility and attachment to the extracellular matrix.
机译:胃泌素释放肽(GRP)及其受体(GRPR)在结直肠癌(CRC)中表达时充当形态发生剂,通过在重构和通过增强细胞来延缓肿瘤细胞转移的情况下调节细胞运动来促进更好分化表型的假设。 -矩阵附件。尽管我们已经表明这些过程是由粘着斑激酶(FAK)介导的,但GRP诱导的FAK激活的下游目标是未知的。由于成骨细胞分化是由FAK引发的ICAM-1上调介导的(Nakayamada S,Okada Y,Saito K,Tamura M,Tanaka Y.J Biol Chem 278:45368-45374,2003),我们确定了GRP诱导的激活是否激活FAK可以改变CRC中ICAM-1的表达,并且可以确定ICAM-1对介导GRP形态发生特性的贡献。 Caco-2和HT-29细胞可变表达GRP / GRPR。当存在GRPR时,这些细胞仅表达ICAM-1。在人类CRC中,GRPR和ICAM-1仅由分化更好的肿瘤细胞表达,ICAM-1位于基底外侧膜。仅在通过FAK的GRPR信号转导之后才观察到ICAM-1表达。为了研究ICAM-1表达对肿瘤细胞运动的影响,在有或没有GRPR拮抗剂或ICAM-1单克隆抗体的情况下培养表达GRP,GRPR和ICAM-1的CRC细胞。仅在不存在拮抗剂或ICAM-1抗体的情况下,CRC细胞在重塑的情况下参与定向运动,并高度粘附于细胞外基质。这些数据表明,经由FAK的ICAM-1的GRP上调促进了肿瘤细胞的运动性以及对细胞外基质的附着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号